NDC 72526-110 – Erzofri extended-release
Paliperidone Palmitate 351 mg/2.25mL · Injection · Intramuscular
Product NDC72526-110
Product details
- Brand name
- Erzofri extended-release
- Generic name
- Paliperidone palmitate
- Labeler
- Shandong Luye Pharmaceutical Co., Ltd.
- Dosage form
- Injection
- Route
- Intramuscular
- Marketing category
- NDA · NDA216352
- Marketed since
- December 10, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Paliperidone Palmitate 351 mg/2.25mL
Uses, dosage, side effects and warnings for Erzofri extended-release →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 72526-110-11 | 1 SYRINGE, GLASS in 1 KIT (72526-110-11) / 2.25 mL in 1 SYRINGE, GLASS | Dec 10, 2024 |
| 72526-110-21 sample | 1 SYRINGE, GLASS in 1 KIT (72526-110-21) / 2.25 mL in 1 SYRINGE, GLASS | Mar 20, 2025 |
Other Erzofri extended-release products
- 72526-105 Paliperidone Palmitate 39 mg/.25mL · Injection · Shandong Luye Pharmaceutical Co., Ltd.
- 72526-106 Paliperidone Palmitate 78 mg/.5mL · Injection · Shandong Luye Pharmaceutical Co., Ltd.
- 72526-107 Paliperidone Palmitate 117 mg/.75mL · Injection · Shandong Luye Pharmaceutical Co., Ltd.
- 72526-108 Paliperidone Palmitate 156 mg/mL · Injection · Shandong Luye Pharmaceutical Co., Ltd.
- 72526-109 Paliperidone Palmitate 234 mg/1.5mL · Injection · Shandong Luye Pharmaceutical Co., Ltd.